Unusual 11 Mid-Day Movers 1/15: BKUNA, CYPB, JAV, FAZ Higher; SSCC, TRMB, ARTC, SAY Lower

January 15, 2009 12:30 PM EST

Smurfit-Stone Container Corp. (Nasdaq: SSCC) 80.6% LOWER; highlighted in a WSJ article, Smurfit-Stone has told lenders that it could file for bankruptcy given weakening sales caused by the global economic crisis. The stock is seeing extremely heavy volume today, with over 77 million trades already today, compared to the stock's average daily volume of just under 4 million shares.

BankUnited Financial Corporation (Nasdaq: BKUNA) 35.5% HIGHER; trading higher on reports investment fund Vanquish Capital Group LLC is close to a deal to buy the troubled thrift. American Banker reported that Vanquish, working with an investment group including W.L. Ross & Co. LLC and Cerberus Capital Management LP, has agreed to invest $500 million for majority control of the company.

Trimble (Nasdaq: TRMB) 27% LOWER; revises its Q4 sales guidance to a range of $268-$269 million, versus the consensus of $313.16 million. EPS for the quarter move to $0.22-$0.24, versus the Street estimate of $0.33.

ArthroCare Corp. (Nasdaq: ARTC) 25.1% LOWER; announced that it received a letter from the Nasdaq Listing Qualifications Panel, dated January 14, 2009, stating that the Panel has determined to suspend and delist trading of the Company's common stock on The Nasdaq Stock Market ("Nasdaq"). The suspension will become effective at the open of trading on Friday, January 16, 2009. ArthroCare has requested a review from the Nasdaq Listing and Hearing Review Council, which could result in staying the Panel's decision to delist the Company's common stock from Nasdaq.

Cypress Bioscience, Inc. (Nasdaq: CYPB) 24.7% HIGHER; Forest Laboratories and Cypress Bioscienceannounced that Savella, a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the FDA for the management of fibromyalgia. Click here for the full report.

Satyam Computer Services Ltd. (NYSE: SAY) 24.4% LOWER; India's government said it has no plans to give the company a bailout following last week's news that the Chairman falsified earnings and assets for years.

Marshall & Ilsley Corporation (NYSE: MI) 22.4% LOWER; reports Q4 loss of $1.55, versus the analyst estimate of $0.07. Marshall & Ilsley Corporation announced that the quarterly cash dividend has been reduced to $0.01 per share. The next regular dividend declaration date is in February 2009. The company also announced that Proxy officers and all other executive officers will receive no bonuses for 2008. Also on the expense initiative front, M&I will eliminate approximately 830 positions, or 8% of its workforce.

Javelin Pharmaceuticals, Inc. (NYSE: JAV) 20.9% HIGHER; entered into an exclusive European marketing partnership for Dyloject with Therabel Pharma N.V., worth up to $71 million in upfront, sales, and regulatory milestone payments plus a double digit royalty on future sales. Javelin will receive approximately $12 million in upfront cash payments, inclusive of its Dyloject inventory, and up to $59.5 million in sales and regulatory milestones. In addition, Javelin will earn a double digit royalty on future net sales of Dyloject in all countries covered by the agreement.

Financial Bear 3x (NYSE: FAZ) 17.1% HIGHER; this short ETF is surging for the second day in a row following several bad news items related to major financial companies such as Citi and Bank of America. JPMorgan (NYSE: JPM) reported better-than-expected Q4 results this morning, but the stock is trading relatively flat on news that the US government may need to give BofA further financial aid. Goldman Sachs (NYSE: GS) is down 7% to $70.27, US Bancorp (NYSE: USB) is down 6.5% to $19.67 and Morgan Stanley is down 7.9% to $15.85.

CLARCOR Inc. (NYSE: CLC) 11.8% HIGHER; reports Q4 EPS of $0.56, 2 cents better than the analyst estimate of $0.54. Revenue for the quarter was $265.98 million, versus the consensus of $273.06 million. Sees FY09 EPS of $1.78-$2.08, versus the consensus of $1.89.

Amphenol Corporation (NYSE: APH) 8.5% HIGHER; reports Q4 EPS of $0.56, 6 cents better than the analyst estimate of $0.50 and up 2% from Q407. Revenue for the quarter was down 3% to $755.3 million, versus the consensus of $728.71 million. Sees Q1 sales of $650-$665 million and EPS of $0.39-$0.41. The Street is expecting Q1 sales and EPS of $664.84 million and $0.43, respectively.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• Cerberus Capital
• JPMorgan
• Goldman Sachs
• Citi
• Morgan Stanley
• Banc of America
• Dividend
• Unusual 11 Mid-Day Movers
• Bankruptcy

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?